China biotech deals are poised for growth as Washington shifts away from imposing broad restrictions, analysts say. This positive outlook...
-
-
Recent Updates
- China’s MLCC Market Evolution Amid Tech Shift
- China’s Rare Earth Dominance Shifts Trump’s Strategy before Meeting with Xi
- Economic Tensions Rise Ahead of President Xi’s Visit to Washington
- Nvidia CEO Dismisses Fear of AI Extinction, Echoes Trump’s China Concerns
- High-Stakes Encounter Between Trump and Xi Jinping on the Horizon
- Impressive Surge of Tech Stocks Leads Market Rally Amid Oscillating Oil Prices and Interest Rates
- China’s Economic Influence Challenged by US, Japan, and South Korea Pre-Xi Summit Talks
- MetaOptics Secures Up to $10 Million Investment from White Lion Capital, Welcomes First U.S. Institutional Investor to Drive Ultra-Lens Technology Expansion in America
- Pylon Technology Commences Mass Production of 588Ah and 601Ah Energy Storage Cells
- Chinese Regulators Slow Humanoid Robot IPOs Amid Valuation Concerns
Blogroll